Ohwada A, Takahashi H, Uchida K, Nukiwa T, Kira S
Department of Respiratory Medicine, School of Medicine, Juntendo University, Tokyo, Japan.
Am Rev Respir Dis. 1992 Jun;145(6):1491-4. doi: 10.1164/ajrccm/145.6.1491.
A 16-yr-old male patient with heterozygous protein C deficiency developed acute pulmonary thromboembolism. The patient had low levels of plasma protein C antigen and activity (33 and 35% of normal, respectively). Analysis of the protein C gene by polymerase chain reaction (PCR) and direct sequencing revealed a nucleotide substitution (Arg169CGG----Trp169 TGG) in exon VII. This mutation is identical with protein C Tochigi, and the substituted amino acid is located at the cleavage site of the activation peptide of protein C. The mutant sequence was also detected in the mRNA transcripts of protein C gene. These results suggest that the possible mechanism of plasma protein C reduction is impaired stability or susceptibility to protein degradation during intracellular processing or after secretion into plasma. As this is a third independent case of protein C Tochigi with thromboembolism, the mutation of Arg169 (CGG) to Trp169 (TGG) in the protein C gene may be a "hot spot" and a common type of genetic lesion in congenital protein C deficiency with thromboembolic complications.
一名16岁男性杂合子蛋白C缺乏症患者发生急性肺血栓栓塞。该患者血浆蛋白C抗原和活性水平较低(分别为正常水平的33%和35%)。通过聚合酶链反应(PCR)和直接测序对蛋白C基因进行分析,发现在外显子VII中有一个核苷酸替代(Arg169 CGG----Trp169 TGG)。此突变与蛋白C枥木突变相同,被替代的氨基酸位于蛋白C激活肽的裂解位点。在蛋白C基因的mRNA转录本中也检测到了突变序列。这些结果表明,血浆蛋白C降低的可能机制是在细胞内加工过程中或分泌到血浆后,稳定性受损或易受蛋白降解影响。由于这是蛋白C枥木突变伴血栓栓塞的第三例独立病例,蛋白C基因中Arg169(CGG)突变为Trp169(TGG)可能是先天性蛋白C缺乏伴血栓栓塞并发症的一个“热点”和常见的遗传病变类型。